Feb 19 (Reuters) - Orion Oyj ORNBV.HE :
* ORION TO INVESTIGATE POSSIBLE OUTSOURCING OF ITS
PHARMACEUTICAL
PRODUCTION IN KUOPIO, FINLAND
* IS EVALUATING POSSIBLE OUTSOURCING OF ITS PHARMACEUTICAL
PRODUCTION IN KUOPIO, PART OF ITS GLOBAL OPERATIONS FUNCTION, TO
AN ENTITY OUTSIDE FINLAND
* EVALUATION IS DUE TO LOW COMPETITIVENESS OF PLANT, LOW
CAPACITY
UTILISATION, INCREASING QUALITY REQUIREMENTS IN PHARMACEUTICAL
INDUSTRY, AND HIGH INVESTMENT NEEDS
* VOLUMES OF PLANT ARE LOW AND DUE TO LACK OF
COMPETITIVENESS,
OUTLOOK FOR GROWTH IS VERY LIMITED
* PRODUCTS CURRENTLY MANUFACTURED IN KUOPIO WOULD CONTINUE
TO BE
PART OF ORION'S PRODUCT PORTFOLIO ALSO IN FUTURE
* ESTIMATED TIME SCOPE IS THAT PLANT WOULD CONTINUE TO
OPERATE
UNTIL AT LEAST SUMMER OF 2026
* BASIS FOR POSSIBLE OUTSOURCING WOULD BE LACK OF
COMPETITIVENESS
OF KUOPIO PLANT AND HIGH INVESTMENT NEEDS OF PLANT
* COMPANY HAS TODAY ISSUED A NEGOTIATION PROPOSAL IN
ACCORDANCE
WITH CO-OPERATION ACT WITHIN UNDERTAKINGS REGARDING
REORGANISATION OF OPERATIONS AND POSSIBLE PERSONNEL REDUCTIONS
* OTHER EMPLOYEES WORKING IN KUOPIO PLANT ARE NOT IMPACTED
BY
STATUTORY NEGOTIATIONS
* STATUTORY NEGOTIATIONS INCLUDE ENTIRE PERSONNEL IN
OPERATIONS
AND FUNCTIONS WHICH SUPPORT PRODUCTION IN KUOPIO PLANT,
ALTOGETHER ABOUT 40 PEOPLE
Source text for Eikon: ID:nGNE22PnXn
Further company coverage: ORNBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))